ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements with these filters
Asarfi Hospital Limited filed its half-yearly shareholding pattern under Regulation 31(1)(b) for the period ended 30 September 2026. The filing shows promoter and public holdings, with no transaction or corporate event.
Asarfi Hospital Ltd has filed its shareholding pattern for the quarter ended September 30, 2026. This disclosure outlines the current distribution of equity shares.
Asarfi Hospital Ltd announced that CRISIL Ratings upgraded its bank facilities credit rating. The total rated bank facilities are now ₹60 Crore, enhanced from ₹46.5 Crore.
Asarfi Hospital Ltd's 21st Annual General Meeting held on September 18, 2026, saw shareholder approval for financial statements, director reappointment, and migration to the BSE Main Board.
Asarfi Hospital Limited has submitted its Annual Report for the Financial Year 2025-26 in compliance with SEBI Listing Regulations.
Asarfi Hospital Limited has appointed M/s Ashutosh Kumar Sinha & Co as the Cost Auditor for the financial year 2026-27, as approved by the Board.
Asarfi Hospital approved its 21st AGM, appointment of auditors, and migration from BSE SME to the BSE Main Board and NSE.
Asarfi Hospital Ltd has scheduled a board meeting for August 25, 2026, to discuss the AGM and proposed migration to the BSE Main Board.
Asarfi Hospital Ltd reported revenue from operations of ₹47.5 Cr (+33.1% YoY) and net profit of ₹4.3 Cr (+38.7% YoY) for Q1 FY27.
Asarfi Hospital reports strong Q1’FY27 growth with Consolidated Revenue up 33.2% YoY to ₹47.5 Cr and PAT increasing 36.7% to ₹4.3 Cr.
Asarfi Hospital Ltd reported revenue from operations of ₹47.5 Cr (+33.1% YoY) and net profit of ₹4.3 Cr (+38.7% YoY) for Q1 FY27.
Asarfi Hospital Ltd has scheduled a board meeting on August 7, 2026, to consider and approve the unaudited financial results for the quarter ending June 30, 2026.
Asarfi Hospital's board approved participating in a PPP Medical College project. This includes a refundable bid security of ₹3.52 Crore.
Asarfi Hospital Limited reported zero deviation in the utilization of ₹26.94 Crore raised via its IPO. Funds were deployed for hospital capital expenditure and land acquisition.
Asarfi Hospital Limited reported strong FY26 performance with 42% revenue growth and 58% PAT growth. Management targets scaling to 500+ beds and INR 400cr revenue by FY28.
Asarfi Hospital Ltd reported ₹173.5 Crore revenue for FY26, a 42% YoY increase. EBITDA margins reached 20%, driven by improved realizations and specialty-led growth.
Asarfi Hospital Ltd reported revenue from operations of ₹92.1 Cr (+36.2% YoY) and net profit of ₹9.3 Cr (+47.6% YoY) for H2 FY26.
Asarfi Hospital Limited approved audited standalone and consolidated financial results for the fiscal year ended March 2026. The results received an unmodified opinion from auditors.
Asarfi Hospital Limited has scheduled a Board Meeting for May 11, 2026, to approve audited financial results for the year ended March 31, 2026. The company also announced a trading window closure from April 1 to May 31, 2026, for designated persons.